Clinical Trial Update: Neoantigen-loaded DC Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After First-line Treatment [NA]

View source ↗

Summary

This clinical trial investigates a combination therapy for advanced non-small cell lung cancer involving a neoantigen-loaded dendritic cell vaccine, a PD-1 inhi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Neoantigen-loaded dendritic cell vaccine
• PD-1 inhibitor

Snippet

Sponsor: The First Affiliated Hospital of Nanchang University | Conditions: Advanced NSCLC | NA | Status: RECRUITING